GSA CAPITAL PARTNERS LLP - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 2 filers reported holding NPS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$540,000
-55.8%
15,100
-67.9%
0.04%
-40.6%
Q3 2014$1,222,000
+10.9%
47,018
+41.0%
0.06%
+28.0%
Q2 2014$1,102,000
-39.5%
33,337
-45.2%
0.05%
-61.5%
Q1 2014$1,821,000
+89.7%
60,846
+92.4%
0.13%
+71.1%
Q4 2013$960,000
-14.4%
31,625
-10.3%
0.08%
-14.6%
Q3 2013$1,121,000
+39.1%
35,251
-33.9%
0.09%
-7.3%
Q2 2013$806,00053,3290.10%
Other shareholders

There were no reported owners of NPS PHARMACEUTICALS INC in Q1 2015.

NameSharesValueWeighting ↓
View complete list of NPS PHARMACEUTICALS INC shareholders